Drawing for ANDA MEDS

USPTO serial 87105832

ANDA MEDS

Reviewed by CopyMark Law Group

Reg. 5429145Status 702Registered
Filing date
Status date
Registration date
Mar 20, 2018
Examiner
GOODSAID, IRA
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with ANDA MEDS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lori Wolfe

Lori Wolfe Teva Pharmaceuticals USA, Inc.400 Interpace ParkwayParsippany, NJ 07054United States

Goods and services

ClassDescriptionStatusFirst use
035On-line ordering services featuring pharmaceutical products and medical suppliesACTIVEJan 1, 2014

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 4, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 4, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 4, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 4, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 4, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 31, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Oct 31, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Oct 30, 2024EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Sep 24, 2024PR23POST REGISTRATION ACTION MAILED - SEC. 8 & 15—
Sep 24, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 20, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Mar 20, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Mar 20, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 10, 2018SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 9, 2018CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 9, 2018SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 7, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 25, 2018IUAFUSE AMENDMENT FILED—
Jan 25, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 8, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 13, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 13, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 24, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 9, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 19, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 19, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 18, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 18, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 25, 2016CEPECOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED—
Oct 25, 2016ALIEASSIGNED TO LIE—
Oct 25, 2016GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Oct 25, 2016GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Oct 25, 2016CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Oct 25, 2016DOCKASSIGNED TO EXAMINER—
Oct 10, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 22, 2016MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 21, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 19, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance